3175 results for «367»

Filter By

3175 results

Challenges in the treatment of patients with left main disease

21 May 2025 – From EuroPCR 2025

Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.

Challenges in the treatment of patients with left main disease

Novelties and future developments of sympathetic denervation to control blood pressure

21 May 2025 – From EuroPCR 2025

Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.

Novelties and future developments of sympathetic denervation to control blood pressure

Non-antiplatelet drugs interventionalists should be aware of

21 May 2025 – From EuroPCR 2025

Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.

Non-antiplatelet drugs interventionalists should be aware of

Left main stenting techniques

21 May 2025 – From EuroPCR 2025

Examine advanced left main stenting techniques including DK crush and mini-crush strategies for complex bifurcation lesions. This session reviews stent malapposition in trifurcations, novel stent expansion outcomes, bifurcation angle correlations, and clinical results of double kissing crush versus culotte techniques.

Left main stenting techniques

Transcatheter management of structural defects

20 May 2025 – From EuroPCR 2025

Explore the transcatheter management of structural cardiac defects with challenging clinical scenarios including ventricular septal ruptures and post-TAVI complications. This session emphasizes multidisciplinary approaches and strategic planning to avert catastrophic outcomes and optimize patient care.

Transcatheter management of structural defects

Techniques for the treatment of left main lesions

20 May 2025 – From EuroPCR 2025

Discover contemporary techniques for treating left main coronary artery lesions with a focus on ultra low-contrast PCI, management of calcified Medina 0-0-1 lesions, and troubleshooting intravascular lithotripsy. This session provides practical insights into complex lesion treatment to enhance safety and efficacy.

Techniques for the treatment of left main lesions

Invasive treatment of refractory angina

20 May 2025 – From EuroPCR 2025

Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.

Invasive treatment of refractory angina

Nurses and allied professionals abstracts session

20 May 2025 – From EuroPCR 2025

Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.

Nurses and allied professionals abstracts session

Hotline TAVI 1: extended analysis of the randomised trials

21 May 2025 – From EuroPCR 2025

Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.

Hotline TAVI 1: extended analysis of the randomised trials

How to avoid and manage complications in CTO interventions

21 May 2025 – From EuroPCR 2025

Learn how to anticipate, prevent, and manage complications during complex CTO interventions. This session presents real-world cases including donor artery dissection, main and distal vessel perforations, and the importance of teamwork in the cath lab for successful complication management.

How to avoid and manage complications in CTO interventions

Clinical outcomes of left main PCI

21 May 2025 – From EuroPCR 2025

This session reviews clinical outcomes of left main PCI in various contexts including ACS, complex lesion risk stratification with BCIS-CHIP score, and spontaneous coronary artery dissection. It also compares double-stent techniques and examines five-year results to guide clinical decision-making.

Clinical outcomes of left main PCI

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial

29 Mar 2025

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

Author

Aaysha Cader

Author

Ali Nazmi Calik
Routine cerebral embolic protection in TAVI: the British Heart Foundation (BHF) PROTECT-TAVI trial

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
Didn’t find what you were looking for?